Development of either split tolerance or robust tolerance along with humoral tolerance to donor and third-party alloantigens in nonmyeloablative mixed chimeras.

PubWeight™: 0.95‹?› | Rank: Top 15%

🔗 View Article (PMID 18390699)

Published in J Immunol on April 15, 2008

Authors

William F N Chan1, Haide Razavy, Bin Luo, A M James Shapiro, Colin C Anderson

Author Affiliations

1: Department of Medical Microbiology and Immunology, Surgical-Medical Research Institute, University of Alberta, Edmonton, Alberta, Canada.

Articles by these authors

Five-year follow-up after clinical islet transplantation. Diabetes (2005) 7.86

Sirolimus-based immunosuppression is associated with increased survival after liver transplantation for hepatocellular carcinoma. Hepatology (2010) 3.54

Improvement in outcomes of clinical islet transplantation: 1999-2010. Diabetes Care (2012) 3.20

CD4 cells can be more efficient at tumor rejection than CD8 cells. Blood (2007) 2.68

Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatology (2009) 2.51

Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes (2002) 2.36

Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes (2009) 2.31

Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation. Diabetes (2004) 2.22

Cell encapsulation: promise and progress. Nat Med (2003) 2.18

Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma. Liver Transpl (2008) 2.04

Control of plant trichome development by a cotton fiber MYB gene. Plant Cell (2004) 2.00

Islet graft assessment in the Edmonton Protocol: implications for predicting long-term clinical outcome. Diabetes (2004) 1.98

Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma. Liver Transpl (2004) 1.80

Changes in renal function after clinical islet transplantation: four-year observational study. Am J Transplant (2007) 1.78

Human mesenchymal stem cells protect human islets from pro-inflammatory cytokines. PLoS One (2012) 1.76

Anxiolytic-like activity of oxytocin in male mice: behavioral and autonomic evidence, therapeutic implications. Psychopharmacology (Berl) (2006) 1.63

Combination therapy with sirolimus and interleukin-2 prevents spontaneous and recurrent autoimmune diabetes in NOD mice. Diabetes (2002) 1.61

Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture. Transpl Int (2009) 1.58

BTLA targeting modulates lymphocyte phenotype, function, and numbers and attenuates disease in nonobese diabetic mice. J Leukoc Biol (2009) 1.53

Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. Diabetes (2004) 1.46

Edmonton's islet success has indeed been replicated elsewhere. Lancet (2003) 1.45

Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device. Transplantation (2015) 1.44

Impact of ultra-early coiling on clinical outcome after aneurysmal subarachnoid hemorrhage in elderly patients. Acad Radiol (2011) 1.42

Update on islet transplantation. Cold Spring Harb Perspect Med (2012) 1.40

Beta-score: an assessment of beta-cell function after islet transplantation. Diabetes Care (2005) 1.35

Percutaneous transhepatic pancreatic islet cell transplantation in type 1 diabetes mellitus: radiologic aspects. Radiology (2003) 1.34

Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes (2002) 1.32

Factors influencing the loss of beta-cell mass in islet transplantation. Cell Transplant (2007) 1.27

Current status of clinical islet cell transplantation. Methods Mol Biol (2006) 1.25

Prevention of bleeding after islet transplantation: lessons learned from a multivariate analysis of 132 cases at a single institution. Am J Transplant (2005) 1.23

Interventional strategies to prevent beta-cell apoptosis in islet transplantation. Diabetes (2006) 1.21

Toward development of imaging modalities for islets after transplantation: insights from the National Institutes of Health Workshop on Beta Cell Imaging. Transplantation (2004) 1.17

Enhancing the success of human islet isolation through optimization and characterization of pancreas dissociation enzyme. Am J Transplant (2007) 1.14

Estimation of pancreas weight from donor variables. Cell Transplant (2006) 1.13

Islet isolation and transplantation outcomes of pancreas preserved with University of Wisconsin solution versus two-layer method using preoxygenated perfluorocarbon. Transplantation (2006) 1.12

Histologic graft assessment after clinical islet transplantation. Transplantation (2009) 1.12

Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist. Neuropharmacology (2009) 1.12

XIAP overexpression in human islets prevents early posttransplant apoptosis and reduces the islet mass needed to treat diabetes. Diabetes (2005) 1.12

De novo sirolimus-based immunosuppression after liver transplantation for hepatocellular carcinoma: long-term outcomes and side effects. Transplantation (2007) 1.11

Current status of pancreatic islet transplantation. Clin Sci (Lond) (2006) 1.11

Glucose regulates cyclin D2 expression in quiescent and replicating pancreatic β-cells through glycolysis and calcium channels. Endocrinology (2011) 1.11

Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success. Transplantation (2010) 1.10

Sodium salicylate reduces inhibitory postsynaptic currents in neurons of rat auditory cortex. Hear Res (2006) 1.08

Advances in pancreatic islet transplantation in humans. Diabetes Obes Metab (2006) 1.08

Assessment of glycemic control after islet transplantation using the continuous glucose monitor in insulin-independent versus insulin-requiring type 1 diabetes subjects. Diabetes Technol Ther (2006) 1.08

Comparison of human islet isolation outcomes using a new mammalian tissue-free enzyme versus collagenase NB-1. Transplantation (2010) 1.06

Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse. Diabetes (2006) 1.05

Revascularization of transplanted pancreatic islets and role of the transplantation site. Clin Dev Immunol (2013) 1.04

Ex planta phytoremediation of trichlorophenol and phenolic allelochemicals via an engineered secretory laccase. Nat Biotechnol (2004) 1.03

Factors influencing the collagenase digestion phase of human islet isolation. Transplantation (2007) 1.03

Surgical aspects of human islet isolation. Islets (2010) 1.03

Circumportal pancreas and islet isolation. Surgery (2008) 1.03

Islet transplantation in patients with diabetes mellitus: choice of immunosuppression. BioDrugs (2004) 1.01

A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson's disease. J Pharmacol Exp Ther (2012) 1.01

Effect of different induction strategies on effector, regulatory and memory lymphocyte sub-populations in clinical islet transplantation. Transpl Int (2008) 1.00

Multiple combination therapies involving blockade of ICOS/B7RP-1 costimulation facilitate long-term islet allograft survival. Am J Transplant (2004) 1.00

Risks and side effects of islet transplantation. Curr Diab Rep (2004) 1.00

Beta-cell transplantation for diabetes therapy. Lancet (2008) 0.99

The effect of Neuroform stent-assisted coil embolization of wide-necked intracranial aneurysms and clinical factors on progressive aneurysm occlusion on angiographic follow-up. J Clin Neurosci (2012) 0.99

Application of perioperative immunonutrition for gastrointestinal surgery: a meta-analysis of randomized controlled trials. Asia Pac J Clin Nutr (2007) 0.98

Current indications for pancreas or islet transplant. Diabetes Obes Metab (2006) 0.98

Technical aspects of islet preparation and transplantation. Transpl Int (2003) 0.98

Quality of life after islet transplant: impact of the number of islet infusions and metabolic outcome. Transplantation (2007) 0.98

Sodium salicylate suppresses serotonin-induced enhancement of GABAergic spontaneous inhibitory postsynaptic currents in rat inferior colliculus in vitro. Hear Res (2007) 0.97

Sensitivity enhancement of strain sensing utilizing a differential pair of fiber Bragg gratings. Sensors (Basel) (2012) 0.97

Caspase inhibitor therapy enhances marginal mass islet graft survival and preserves long-term function in islet transplantation. Diabetes (2007) 0.97

Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma. Mol Carcinog (2009) 0.96

An ATP-binding cassette transporter GhWBC1 from elongating cotton fibers. Plant Physiol (2003) 0.95

Porcine marginal mass islet autografts resist metabolic failure over time and are enhanced by early treatment with liraglutide. Endocrinology (2009) 0.95

Thymic cortical epithelium induces self tolerance. Eur J Immunol (2005) 0.95

The ability of natural tolerance to be applied to allogeneic tissue: determinants and limits. Biol Direct (2007) 0.95

Vascular endothelial growth factor expression in hepatic epithelioid hemangioendothelioma: Implications for treatment and surgical management. Liver Transpl (2010) 0.95

Role of imaging in clinical islet transplantation. Radiographics (2010) 0.95

The caspase selective inhibitor EP1013 augments human islet graft function and longevity in marginal mass islet transplantation in mice. Diabetes (2008) 0.95

Decellularization reduces the immune response to aortic valve allografts in the rat. J Thorac Cardiovasc Surg (2005) 0.95

Unraveling the secrets of single donor success in islet transplantation. Am J Transplant (2004) 0.94

Supplemental islet infusions restore insulin independence after graft dysfunction in islet transplant recipients. Transplantation (2010) 0.94

Pancreas divisum: a study of the cadaveric donor pancreas for islet isolation. Pancreas (2005) 0.94

High prevalence of ovarian cysts in premenopausal women receiving sirolimus and tacrolimus after clinical islet transplantation. Transpl Int (2009) 0.93

Neonatal porcine islets exhibit natural resistance to hypoxia-induced apoptosis. Transplantation (2006) 0.93

Renewing functionalized graphene as electrodes for high-performance supercapacitors. Adv Mater (2012) 0.93

A comparison of islet autotransplantation with allotransplantation and factors elevating acute portal pressure in clinical islet transplantation. J Hepatobiliary Pancreat Sci (2012) 0.93

Adaptable silicon-carbon nanocables sandwiched between reduced graphene oxide sheets as lithium ion battery anodes. ACS Nano (2013) 0.93

Effect of core pancreas temperature during cadaveric procurement on human islet isolation and functional viability. Transplantation (2002) 0.93

Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study. J Psychopharmacol (2002) 0.92

Differential expression of miR-125a-5p and let-7e predicts the progression and prognosis of non-small cell lung cancer. Cancer Invest (2014) 0.92

Changes in liver enzymes after clinical islet transplantation. Transplantation (2003) 0.92

Histopaque provides optimal mouse islet purification kinetics: comparison study with Ficoll, iodixanol and dextran. Islets (2011) 0.92

Coinhibitory T-cell signaling in islet allograft rejection and tolerance. Cell Transplant (2006) 0.92

Cordycepin suppresses TNF-α-induced NF-κB activation by reducing p65 transcriptional activity, inhibiting IκBα phosphorylation, and blocking IKKγ ubiquitination. Int Immunopharmacol (2012) 0.92

Laparoscopic splenectomy for the treatment of refractory immune thrombocytopenia in pregnancy. J Obstet Gynaecol Can (2005) 0.91

Differential effects of sodium salicylate on current-evoked firing of pyramidal neurons and fast-spiking interneurons in slices of rat auditory cortex. Hear Res (2009) 0.91